Advanstar for sale

Share this article:

Advanstar, the largest commercial medical publisher in the U.S., is up for sale.

Well, maybe.

After earlier dismissing talk of a sale as "highly speculative" "market rumors," the business publishing powerhouse today released a statement saying it is "exploring strategic alternatives, including a possible sale of the company," but cautioning that "there can be no assurance that the exploration of strategic alternatives will lead to a transaction."

The sale, first reported in Sunday's New York Post, follows that of six Advanstar divisions to Questex in April for $185 million. The firm, which now holds Life Sciences, Fashion and Powersports portfolios, divested its IT & Communications, Travel & Hospitality, Beauty, Home Entertainment, Abilities and Portfolio groups in the April sale.     

Advanstar's owner, Credit Suisse First Boston, declined comment.

Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Media

Five things for pharma marketers to know: Wednesday, October 22

Five things for pharma marketers to know: ...

Novo partners with YouTube star for diabetes vids; hedge fund wants Amgen to split up; J&J ramps up Ebola vaccine production.

Mucinex gets a revamp

Mucinex gets a revamp

After 10 years of "Mucinex In. Mucus Out," the congestion-relief treatment gets a new look from Reckitt Beckinser's recently appointed AOR McCann New York.

Mixed reaction to a health-centric Facebook feature

Mixed reaction to a health-centric Facebook feature

The ACLU is among those questioning the positives of the rumored healthcare effort.